Raymed Pharmaceuticals Limited, a active public limited company, was established on 10 January 1995 in U T, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231CH1995PLC015598. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.71 M.
It upholds a compliant status. Employing 8 professional, Its leadership includes Tarsem Kumar Ruby (Director), Veeta Sharma (Director), Shivansh Sharma (Director). Past directors included Shivansh Sharma, Sanjay Jhamb, Sat Parkash Mittal. It holds ₹4.46 Cr open charges and ₹8.66 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 859Manimajra Chandigarh, U T, Chandigarh, 160101.
U24231CH1995PLC015598
015598
10 January 1995
₹1.00 Cr
₹1.71 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Raymed Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarsem Kumar Ruby | Director | 10 Jan 1995 | Current |
| Veeta Sharma | Director | 30 Mar 1997 | Current |
| Shivansh Sharma | Director | 17 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 25 Sep 2015 | Past |
| Pramod Abcsdd | Director | 06 Dec 2022 | Past |
| Pramod Abcsdd | Director | 31 Aug 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raymed Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.29% increase. The company also saw a substantial improvement in profitability, with a 91.08% increase in profit. The company's net worth Soared by an impressive increase of 34.24%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Raymed Pharmaceuticals had a promoter holding of 40.67% and a public holding of 59.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,600,000.00
₹8,660,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2023 | Axis Bank Limited | ₹6.00 M | Open |
| 19 Jun 2023 | Hdfc Bank Limited | ₹8.00 M | Open |
| 26 Dec 2022 | Hdfc Bank Limited | ₹3.00 Cr | Open |
| 08 Nov 2004 | Union Bank Of India | ₹0.60 M | Open |
| 23 Dec 2004 | Union Bank Of India | ₹0.16 M | Satisfied |
Explore comprehensive loan charge details -
Raymed Pharmaceuticals has a workforce of 8 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Raymed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymed Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Raymed Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Raymed Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 26 Dec 2022 with Charge ID 100669059 was modified on 12 Mar 2024. was recorded as a recent event.
Progress on A charge with Axis Bank Limited amounted to Rs. 0.60 Cr with Charge ID 100781239 was registered on 30 Aug 2023. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100770796 was registered on 19 Jun 2023. was recorded as a recent event.
Progress on A charge registered on 23 Dec 2004 via Charge ID 90170068 with Union Bank Of India was fully satisfied on 05 Apr 2023. was documented.
The CIN of Raymed Pharmaceuticals Limited is U24231CH1995PLC015598.
Raymed Pharmaceuticals Limited is headquartered at 859Manimajra Chandigarh, U T, Chandigarh, 160101.
Raymed Pharmaceuticals Limited was incorporated on 10 January 1995.
The current directors of Raymed Pharmaceuticals Limited are
The primary industry of Raymed Pharmaceuticals Limited is Manufacturing.
Raymed Pharmaceuticals Limited is unlisted.
The authorized capital of Raymed Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹1.71 M.
The compliance status of Raymed Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX